Patrice RINGOT

Mr. Patrice RINGOT


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
PMPierre Monnin
Pierre Monnin
JLJoël Legrand
Joël Legrand
GHGraziella Husson
Graziella Husson
PRPatrice RINGOT
Patrice RINGOT
ATAndon Tchechmedjiev
Andon Tchechmedjiev
ACAdrien Coulet
Adrien Coulet
Background: Pharmacogenomics (PGx) studies how genomic variations impact variations in drug response phenotypes. Knowledge in pharmacogenomics is typically composed of units that have the form of ternary relationships gene variant – drug – adverse event. Such a relationship states that an adverse event may occur for patients having the specified gene variant and being exposed to the specified drug. State-of-the-art knowledge in PGx is mainly available in reference databases such as PharmGKB and reported in scientific biomedical literature. But, PGx knowledge can also be discovered from clinical data, such as Electronic Health Records (EHRs), and in this case, may either correspond to new knowledge or confirm state-of-the-art knowledge that lacks “clinical counterpart” or validation. For this reason, there is a need for automatic comparison of knowledge units from distinct sources. Results: In this article, we propose an approach, based on Semantic Web technologies, to represent and compare PGx knowledge units. To this end, we developed PGxO, a simple ontology that represents PGx knowledge units and their components. Combined with PROV-O, an ontology developed by the W3C to represent provenance information, PGxO enables encoding and associating provenance information to PGx relationships. Additionally, we introduce a set of rules to reconcile PGx knowledge, i.e. to identify when two relationships, potentially expressed using different vocabularies and levels of granularity, refer to the same, or to different knowledge units. We evaluated our ontology and rules by populating PGxO with knowledge units extracted from PharmGKB (2701), the literature (65,720) and from discoveries reported in EHR analysis studies (only 10, manually extracted); and by testing their similarity. We called PGxLOD (PGx Linked Open Data) the resulting knowledge base that represents and reconciles knowledge units of those various origins. Conclusions: The proposed ontology and reconciliation rules constitute a first step toward a more complete framework for knowledge comparison in PGx. In this direction, the experimental instantiation of PGxO, named PGxLOD, illustrates the ability and difficulties of reconciling various existing knowledge sources.

20 April 2017 in Journal of Biomedical Semantics
Verified
Journal Article
Open access
PDF file
KDKevin Dalleau
Kevin Dalleau
YMYassine Marzougui
Yassine Marzougui
SSSébastien Da Silva
Sébastien Da Silva
PRPatrice RINGOT
Patrice RINGOT
NNNdeye Coumba Ndiaye
Ndeye Coumba Ndiaye
ACAdrien Coulet
Adrien Coulet
A standard task in pharmacogenomics research is identifying genes that may be involved in drug response variability, i.e., pharmacogenes. Because genomic experiments tended to generate many false positives, computational approaches based on the use of background knowledge have been proposed. Until now, only molecular networks or the biomedical literature were used, whereas many other resources are available. We propose here to consume a diverse and larger set of resources using linked data related either to genes, drugs or diseases. One of the advantages of linked data is that they are built on a standard framework that facilitates the joint use of various sources, and thus facilitates considering features of various origins. We propose a selection and linkage of data sources relevant to pharmacogenomics, including for example DisGeNET and Clinvar. We use machine learning to identify and prioritize pharmacogenes that are the most probably valid, considering the selected linked data. This identification relies on the classification of gene–drug pairs as either pharmacogenomically associated or not and was experimented with two machine learning methods –random forest and graph kernel–, which results are compared in this article. We assembled a set of linked data relative to pharmacogenomics, of 2,610,793 triples, coming from six distinct resources. Learning from these data, random forest enables identifying valid pharmacogenes with a F-measure of 0.73, on a 10 folds cross-validation, whereas graph kernel achieves a F-measure of 0.81. A list of top candidates proposed by both approaches is provided and their obtention is discussed.

22 May 2019 in Information
Verified
Journal Article
Open access
PDF file
DMDenis Maurel
Denis Maurel
EMEnza Morale
Enza Morale
NTNICOLAS THOUVENIN
NICOLAS THOUVENIN
PRPatrice RINGOT
Patrice RINGOT
ATAngel Turri
Angel Turri
Istex is a database of twenty million full text scientific papers bought by the French Government for the use of academic libraries. Papers are usually searched for by the title, authors, keywords or possibly the To authorize new types of queries of Istex, we implemented a system of named entity recognition on all papers and we offer users the possibility to run searches on these entities. After the presentation of the French Istex project, we detail in this paper the named entity recognition with CasEN, a cascade of graphs, implemented on the Unitex Software. CasEN exists in French, but not in English. The first challenge was to build a new cascade in a short time. The results of its evaluation showed a good Precision measure, even if the Recall was not very good. The Precision was very important for this project to ensure it did not return unwanted papers by a query. The second challenge was the implementation of Unitex to parse around twenty millions of documents. We used a dockerized application. Finally, we explain also how to query the resulting Named entities in the Istex website.